Joseph C Papa insider trades: Emergent BioSolutions (EBS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joseph reports to the SEC
and 2 more companies
Open-market buys and sales
44 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 13, 2025 | EBS | ↑ Buy | 60,000 | $5.83 | $350K | Direct | May 15, 2025 (2d) |
| Dec 9, 2022 | CADL | ↑ Buy | 38,032 | $1.92 | $73K | Direct | Dec 12, 2022 (3d) |
| Mar 16, 2021 | RXDX | ↑ Buy | 15,000 | $19.00 | $285K | Direct | Mar 16, 2021 (0d) |
| Sep 13, 2019 | BHC | ↑ Buy | 30,000 | $23.31 | $699K | Direct | Sep 13, 2019 (0d) |
| Feb 28, 2019 | BHC | ↑ Buy | 30,000 | $23.67 | $710K | Direct | Feb 28, 2019 (0d) |
| Sep 14, 2018 | BHC | ↑ Buy | 30,000 | $22.32 | $670K | Direct | Sep 17, 2018 (3d) |
| Mar 13, 2018 | VRX | ↑ Buy | 30,000 | $16.05 | $482K | Direct | Mar 13, 2018 (0d) |
| Jun 10, 2016 | VRX | ↑ Buy | 202,000 | $24.48 | $4.9M | Direct | Jun 13, 2016 (3d) |
| Dec 28, 2015 | PRGO | ↓ Sell | 10,183 | $147.07 | $1.5M | Direct | Dec 30, 2015 (2d) |
| Mar 24, 2014 | PRGO | ↓ Sell | 10,000 | $157.72 | $1.6M | Direct | Mar 26, 2014 (2d) |
| Feb 14, 2014 | PRGO | ↓ Sell | 5,000 | $150.51 | $753K | Direct | Feb 19, 2014 (5d) |
| Jan 16, 2014 | PRGO | ↓ Sell | 5,000 | $157.59 | $788K | Direct | Jan 21, 2014 (5d) |
| Dec 12, 2013 | PRGO | ↓ Sell | 15,000 | $150.12 | $2.3M | Direct | Dec 16, 2013 (4d) |
| Sep 24, 2013 | PRGO | ↓ Sell | 15,000 | $124.60 | $1.9M | Direct | Sep 26, 2013 (2d) |
| Aug 27, 2013 | PRGO | ↓ Sell | 15,000 | $117.64 | $1.8M | Direct | Aug 29, 2013 (2d) |
| Jul 11, 2013 | PRGO | ↓ Sell | 10,000 | $128.54 | $1.3M | Direct | Jul 15, 2013 (4d) |
| Jun 14, 2013 | PRGO | ↓ Sell | 10,000 | $118.39 | $1.2M | Direct | Jun 18, 2013 (4d) |
| May 15, 2013 | PRGO | ↓ Sell | 5,000 | $120.51 | $603K | Direct | May 17, 2013 (2d) |
| Apr 9, 2013 | PRGO | ↓ Sell | 10,645 | $118.46 | $1.3M | Direct | Apr 11, 2013 (2d) |
| Mar 12, 2013 | PRGO | ↓ Sell | 15,000 | $116.33 | $1.7M | Direct | Mar 14, 2013 (2d) |
| Feb 14, 2013 | PRGO | ↓ Sell | 5,000 | $112.07 | $560K | Direct | Feb 19, 2013 (5d) |
| Jan 17, 2013 | PRGO | ↓ Sell | 5,000 | $104.50 | $522K | Direct | Jan 22, 2013 (5d) |
| Dec 14, 2012 | PRGO | ↓ Sell | 15,000 | $103.94 | $1.6M | Direct | Dec 18, 2012 (4d) |
| Nov 15, 2012 | PRGO | ↓ Sell | 15,000 | $100.78 | $1.5M | Direct | Nov 19, 2012 (4d) |
| Oct 10, 2012 | PRGO | ↓ Sell | 15,000 | $117.37 | $1.8M | Direct | Oct 12, 2012 (2d) |
| Sep 21, 2012 | PRGO | ↓ Sell | 15,000 | $116.59 | $1.7M | Direct | Sep 25, 2012 (4d) |
| Aug 30, 2012 | PRGO | ↓ Sell | 10,000 | $109.17 | $1.1M | Direct | Sep 4, 2012 (5d) |
| Jul 18, 2012 | PRGO | ↓ Sell | 10,000 | $114.95 | $1.1M | Direct | Jul 20, 2012 (2d) |
| Jun 20, 2012 | PRGO | ↓ Sell | 10,000 | $114.92 | $1.1M | Direct | Jun 22, 2012 (2d) |
| May 21, 2012 | PRGO | ↓ Sell | 15,912 | $99.22 | $1.6M | Direct | May 23, 2012 (2d) |
| Apr 19, 2012 | PRGO | ↓ Sell | 5,000 | $106.59 | $533K | Direct | Apr 23, 2012 (4d) |
| Mar 22, 2012 | PRGO | ↓ Sell | 5,000 | $102.25 | $511K | Direct | Mar 26, 2012 (4d) |
| Feb 22, 2012 | PRGO | ↓ Sell | 5,000 | $93.73 | $469K | Direct | Feb 24, 2012 (2d) |
| Jan 19, 2012 | PRGO | ↓ Sell | 5,000 | $99.98 | $500K | Direct | Jan 23, 2012 (4d) |
| Dec 29, 2011 | PRGO | ↓ Sell | 10,000 | $99.05 | $990K | Direct | Jan 3, 2012 (5d) |
| Nov 22, 2011 | PRGO | ↓ Sell | 10,180 | $89.43 | $910K | Direct | Nov 23, 2011 (1d) |
| Oct 24, 2011 | PRGO | ↓ Sell | 10,000 | $98.60 | $986K | Direct | Oct 26, 2011 (2d) |
| Sep 22, 2011 | PRGO | ↓ Sell | 10,000 | $93.25 | $933K | Direct | Sep 26, 2011 (4d) |
| Aug 23, 2011 | PRGO | ↓ Sell | 5,000 | $88.34 | $442K | Direct | Aug 25, 2011 (2d) |
| Apr 25, 2011 | PRGO | ↓ Sell | 21,000 | $88.51 | $1.9M | Direct | Apr 27, 2011 (2d) |
| Mar 22, 2011 | PRGO | ↓ Sell | 21,000 | $76.05 | $1.6M | Direct | Mar 24, 2011 (2d) |
| Feb 22, 2011 | PRGO | ↓ Sell | 21,000 | $74.99 | $1.6M | Direct | Feb 23, 2011 (1d) |
| Nov 25, 2009 | PRGO | ↓ Sell | 20,000 | $40.58 | $812K | Direct | Nov 30, 2009 (5d) |
| Dec 2, 2008 | PRGO | ↓ Sell | 30,000 | $33.04 | $991K | Direct | Dec 3, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EBS insiders
Open-market trades in the last 12 months
About Joseph C Papa's insider trades
Joseph C Papa is President and CEO at Emergent BioSolutions (EBS). Since Dec 2, 2008, Joseph has reported 8 open-market purchases worth $8.2M and 36 sales worth $42.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (48 filings), option exercises (43 filings), shares withheld for taxes (25 filings), gifts (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EBS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.